Methodologies and outcomes from the sertraline multicenter flexible- dose trials

Psychopharmacology Bulletin

Volumn 34, Issue 2, 1998, Pages 183-189

  Rapaport, Mark Hyman ^a,c   Wolkow, Robert M ^b   Clary, Cathryn M ^b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Methodology; Outcomes; Panic disorder; Pharmacological treatment; Quality of life; SSRIs

Indexed keywords

SERTRALINE;

ANALYTIC METHOD; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; METHODOLOGY; MULTICENTER STUDY; OUTCOMES RESEARCH; PANIC; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

1-NAPHTHYLAMINE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CLINICAL TRIALS; HUMANS; MULTICENTER STUDIES; PANIC DISORDER; SERTRALINE;

EID: 0031815159     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Ballenger, JC; Burrows, GD; DuPont, JR; Lesser, IM; Noyes, JR; Pecknold, JC; Rifkin, A; and Swinson, RP. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. Arch. Gen. Psychiatry 45:413-422, 1988.
2. Endicott, J; Nee, J; Harrison, W; and Blumenthal, R. Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacol. Bull. 29:321-326, 1993.
3. Guy, W. Clinical Global Impressions (028-CGI). In: ECDEU Assessment Manual for Psychopharmacology. DHEW Pub. No. (ADM)76-338. Rockville, MD: National Institute of Mental Health, 1976. pp. 217-222. [See also National Institute of Mental Health. Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol. Bull. 21(4), 1985.]
4. Guy, W. Clinical Global Impressions (028-CGI). In: ECDEU Assessment Manual for Psychopharmacology. DHEW Pub. No. (ADM)76-338. Rockville, MD: National Institute of Mental Health, 1976. pp. 217-222. [See also National Institute of Mental Health. Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol. Bull. 21(4), 1985.]
5. Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:50-55, 1959.
6. Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:278-296, 1967.
7. Klein, DF, and Fink, M. Psychiatric reaction patterns to imipramine. Am. J. Psychiatry 119:432-438, 1962.
8. Klerman, GL; Coleman, JH; and Purpura, RP. The design and conduct of the Upjohn Cross-National Collaborative Panic Study. Psychopharmacol. Bull. 22:59-64, 1986.
9. Klerman, GL. Overview of the Cross-National Collaborative Panic Study. Arch. Gen. Psychiatry 45:407-412, 1988.
10. Liebowitz, MR. Imipramine in the treatment of panic disorder and its complication. Psychiatr. Clin. North Am. 8:37-47, 1985.
11. Lipsedge, M. Iproniazid and systematic desensitization for severe agoraphobia. Psychopharmacologia 32:67-80, 1973.
12. Shear, K; Sholomskas, D; and Cloitre, M. MC-PAS: The Multicenter-Panic Anxiety Scale. Pittsburgh, PA: University of Pittsburgh School of Medicine, 1992.
13. Shear, MK, and Maser, JD. Standardized assessment for panic disorder research: A conference report. Arch. Gen. Psychiatry 51:346-354, 1994.
14. Sheehan, DV. Diagnosis and psychiatry: Examination of the psychiatric patient. In: Kaplan, HI, and Sadock, BJ. In: Comprehensive Textbook of Psychiatry. Baltimore, MD: Williams & Wilkins, 1989.
15. Spitzer, RL; Williams, JBW; and Gibbon, M. Structured Clinical Interview for DSM-III-R: Patient Version (SCID-P). New York: New York State Psychiatric Institute, 1988.